WASHINGTON, DC – Natural Products Association (NPA) President and CEO Dr. Daniel Fabricant, Ph.D., released the following statement in response to the nomination of Robert Califf, M.D., to lead the Food and Drug Administration (FDA).
“NPA welcomes the return of a Senate confirmed commissioner to lead the Food and Drug Administration. If confirmed, Dr. Califf will be responsible for leading the Agency during one of the most challenging moments in history. We look forward to hearing Dr. Califf’s views on enforcing DSHEA, regulating the rapidly expanding CBD industry, and addressing the issue of adulterated ingredients through the NDI process.”
